Physician scientist in internal medicine, immunology and infectious disease @MHH_life
Hannover Medical School
Joined December 2021
- Tweets43
- Following20
- Followers139
- Likes25
LP.8.1 mRNA vaccionation boosts neutralizatio great also against XFG but much less against BA.3.2.2.
Interested in the neutralization response after the most recent LP.8.1 mRNA vaccination? Have a look at our latest preprtint with @snpoehlm and his team. Fantastic collaboratio as always, thanks to all in the team! doi.org/10.1101/2025.10.21.2…
Thanks to all for another great collaboration on JN.1 vaccination and neutralisation against most recent variants. thelancet.com/journals/lanin…
Georg Behrens retweeted
First lab characterization of the effect of vaccination (JN.1-spike directed) on the emerging XEC variant
biorxiv.org/content/10.1101/… @inflammationHL
Drop-off of neutralization response compared with KP.3.1.1 (current dominant variant) but should still be protective
Interested in morde data about the new JN.1 vaccine? Thanks again to the entire team that made this real
medrxiv.org/cgi/content/shor…
So proud to share our preprint about the new Biontech omicron JN.1 vaccine. Many thanks to our team in Hannover, especially Tine for her enthusiasm and skilled work, and Stefan and Markus in Göttingen. Interested? Here you go
medrxiv.org/content/10.1101/…
Happy to share with you our first human data about the mRNA JN.1 vaccine from Biontech.
medrxiv.org/cgi/content/shor…
Just out. Our first characterisation of BA.2.87.1.
Many thanks to Markus and Stefan @snpoehlm for their great work!
biorxiv.org/content/10.1101/…
Georg Behrens retweeted
Proud to share our latest paper in @cellhostmicrobe! CD4+ & CD8+ T cells induced by prior infection or vaccination maintain effective cross-recognition of the hypermutated SARS-CoV-2 BA.2.86 variant – good news in the fight against emerging variants.
sciencedirect.com/science/ar…
Why does the immune system respond differently strong to mRNA COVID-19 vaccines? Here is part of the answer...
thelancet.com/journals/ebiom…
Georg Behrens retweeted
All data are available on #MedRxiv. Many thanks to G. Behrens & A. Jablonka, who provided us the sera; S. Pöhlmann &M. Hoffmann for their help with the cloning and especially Najat Bdeir, who lead our lab to generate this huge dataset in record time. /end
medrxiv.org/content/10.1101/…
Georg Behrens retweeted
Our paper on #SARSCoV2 BA.2.86 & JN.1 #neutralization is on MedRxiv. These strains have become globally dominant due to their superior #escape of #antibody recognition. We tested why exactly they have these properties & what happens upon an XBB.1.5 adapted #booster shot. 1/9
Georg Behrens retweeted
Two new @CellCellPress papers characterizing the differentiating features of the BA.2.86 variant (which gave rise to JN.1)
cell.com/cell/fulltext/S0092… @ShanLuLiu1 @PankeQu
cell.com/cell/fulltext/S0092… @snpoehlm
Now out at Lancet ID thelancet.com/journals/lanin…
What a great team effort again! So glad to share our first data about immune responses after BNT162b2 XBB.1.5 vaccination at #medRxiv. Many thanks to the Pöhlmann lab @snpoehlm, our friends from the Förster lab at #MHH, and our fantastic team! medrxiv.org/cgi/content/shor…
Strong increase in neutralizing activity against XBB variants and more recently circulating Omicron variants including BA.2.86
medrxiv.org/cgi/content/shor…
